Clinical Trials

The BROADEN Study

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with Familial Partial Lipodystrophy (FPL)

The main purpose of this clinical trial is to determine the effect of volanesorsen on triglyceride levels in patients with FPL, in addition to other measures.

Learn More (http://apociii.com/familial-partial-lipodystrophy-fpl/)